A Pharmacovigilance Signaling System Based on FDA Regulatory Action and Post-Marketing Adverse Event Reports

Empirical Evidence for Selective Reporting of Outcomes in Randomized Trials

An‐Wen Chan, Asbjørn Hróbjartsson, Mette T. Haahr et al. · JAMA · 2004 · 1.9K citations

Public Health, Biostatistics, Meta-analysis +16

Data-Driven Prediction of Drug Effects and Interactions

Nicholas P. Tatonetti, Patrick P. Ye, Roxana Daneshjou et al. · Science Translational Medicine · 2012 · 929 citations

Pharmacy, Pharmacology, Clinical Pharmacology +16

Use of Screening Algorithms and Computer Systems to Efficiently Signal Higher-Than-Expected Combinations of Drugs and Events in the US FDA??s Spontaneous Reports Database

Ana Szarfman, Stella G. Machado, Robert T. O Neill · Drug Safety · 2002 · 688 citations

Pharmacy, Biomedical Informatics, Health Informatics +17

Restoring Study 329: efficacy and harms of paroxetine and imipramine in treatment of major depression in adolescence

Joanna Le Noury, John M. Nardo, David Healy et al. · BMJ · 2015 · 331 citations · Full text

Medicine, Pharmacotherapy, Psychiatry +17

Adverse drug event monitoring at the food and drug administration

Syed Rizwanuddin Ahmad · Journal of General Internal Medicine · 2003 · 248 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +13